Overall survival with sunitinib versus interferon (IFN)-alfa as first-line treatment of metastatic renal cell carcinoma (MRCC) Meeting Abstract


Authors: Negrier, S.; Figlin, R. A.; Hutson, T. E.; Tomczak, P.; Michaelson, M. D.; Bukowski, R. M.; Huang, X.; Kim, S. T.; Chen, I.; Motzer, R. J.
Abstract Title: Overall survival with sunitinib versus interferon (IFN)-alfa as first-line treatment of metastatic renal cell carcinoma (MRCC)
Meeting Title: 33rd ESMO Congress
Journal Title: Annals of Oncology
Volume: 19
Issue: Suppl. 8
Meeting Dates: 2008 Sep 12-16
Meeting Location: Stockholm, Sweden
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2008-09-01
Start Page: viii190
Language: English
ACCESSION: WOS:000259973300587
PROVIDER: wos
DOI: 10.1093/annonc/mdn510
PUBMED: 18790885
Notes: Meeting Abstract: 588PD -- "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer